ENG/中
美国
老虎证券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerGPT
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Palvella Therapeutics
26.97
+3.38
14.33%
盘后:
26.97
0.0000
0.00%
18:21 EDT
成交量:
6.76万
成交额:
178.63万
市值:
3.03亿
市盈率:
-19.90
高:
27.32
开:
24.12
低:
24.00
收:
23.59
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
Palvella Therapeutics
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
125 Strafford Avenue,Suite 360,Wayne,Pennsylvania,United States
官网:
http://www.pieris.com
邮编:
19087
电话:
484 253 1461
传真:
- -
简介:
Palvella Therapeutics, Inc.在内华达的法律下成立于2013年5月24日。该公司是一家生物技术公司,历史上发现并开发了基于Anticalin蛋白的药物,以独特和变革性的方式靶向已验证的疾病途径。2024年3月27日,公司实施了措施,以最大限度地提高其从其合作候选药物临床管道收集潜在里程碑的能力,并保持其考虑其他战略选择的能力。该公司的临床管线包括与合作者合作的免疫肿瘤学或IO双特异性药物,包括靶向PD-L1和4-1BB的S095012(也称PRS-344)、靶向CD228和4-1BB的SGN-BB228(也称PRS-346)以及靶向GPC3和4-1BB的BOS-342(也称PRS-342)。Anticalin蛋白是公司专有的,是一类新型疗法,已在临床上通过与领先制药公司的合作关系得到验证。
董事
名称
职位
James Geraghty
Director and Chairman
Stephen S. Yoder
Director,Chief Executive Officer and President
Ann Barbier
Director
Christopher Kiritsy
Director
Jean Pierre Bizzari
Director
Michael Richman
Director
Steven Prelack
Director
股东
名称
职位
Stephen S. Yoder
Director,Chief Executive Officer and President
Allan Reine
Senior Vice President, Chief Financial Officer and Treasurer
Louis A. Matis
Senior Vice President and Chief Development Officer
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PVLA/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":26.97,"timestamp":1743624000000,"preClose":23.59,"halted":0,"volume":67554,"hourTrading":{"tag":"盘后","latestPrice":26.97,"preClose":26.97,"latestTime":"18:21 EDT","volume":36,"amount":904.37,"timestamp":1743632512639},"delay":0,"floatShares":6497315,"shares":11221307,"eps":-1.355074,"marketStatus":"未开盘","change":3.38,"latestTime":"04-02 16:00:00 EDT","open":24.12,"high":27.322,"low":24,"amount":1786324.950126,"amplitude":0.140822,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.355074,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":23.59,"preHourTrading":{"tag":"盘前","latestPrice":24.69,"preClose":23.59,"latestTime":"04:48 EDT","volume":2,"amount":49.480004,"timestamp":1743583685982},"postHourTrading":{"tag":"盘后","latestPrice":26.97,"preClose":26.97,"latestTime":"18:21 EDT","volume":36,"amount":904.37,"timestamp":1743632512639},"volumeRatio":0.911955,"impliedVol":0.6703,"impliedVolPercentile":0.7333},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":6497315,"roa":"--","roe":"--","lyrEps":0.679019,"volumeRatio":0.911955,"shares":11221307,"dividePrice":0,"high":27.322,"amplitude":0.140822,"preClose":23.59,"low":24,"week52Low":6.2,"pbRate":"-3.46","week52High":29.27,"institutionHeld":0,"latestPrice":26.97,"eps":-1.355074,"divideRate":0,"volume":67554,"delay":0,"ttmEps":-1.355074,"open":24.12,"prevYearClose":12,"prevWeekClose":28.1,"prevMonthClose":27.99,"prevQuarterClose":27.99,"fiveDayClose":27.93,"twentyDayClose":22.34,"sixtyDayClose":13.25},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":534271315,"address":"125 Strafford Avenue,Suite 360,Wayne,Pennsylvania,United States","zipCode":"19087","officePhone":"484 253 1461"},"stockCompanyDetail":{"websiteUrl":"http://www.pieris.com","stockEarnings":[{"period":"1week","weight":-0.0344},{"period":"1month","weight":0.3795},{"period":"3month","weight":1.2475},{"period":"6month","weight":0.6587},{"period":"1year","weight":0.894},{"period":"ytd","weight":1.2475}],"compareEarnings":[{"period":"1week","weight":-0.0072},{"period":"1month","weight":-0.033},{"period":"3month","weight":-0.0344},{"period":"6month","weight":-0.0148},{"period":"1year","weight":0.088},{"period":"ytd","weight":-0.0368}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Palvella Therapeutics, Inc.在内华达的法律下成立于2013年5月24日。该公司是一家生物技术公司,历史上发现并开发了基于Anticalin蛋白的药物,以独特和变革性的方式靶向已验证的疾病途径。2024年3月27日,公司实施了措施,以最大限度地提高其从其合作候选药物临床管道收集潜在里程碑的能力,并保持其考虑其他战略选择的能力。该公司的临床管线包括与合作者合作的免疫肿瘤学或IO双特异性药物,包括靶向PD-L1和4-1BB的S095012(也称PRS-344)、靶向CD228和4-1BB的SGN-BB228(也称PRS-346)以及靶向GPC3和4-1BB的BOS-342(也称PRS-342)。Anticalin蛋白是公司专有的,是一类新型疗法,已在临床上通过与领先制药公司的合作关系得到验证。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.102904},{"month":2,"riseRate":0.5,"avgChangeRate":0.02179},{"month":3,"riseRate":0.5,"avgChangeRate":0.012293},{"month":4,"riseRate":0.2,"avgChangeRate":-0.072506},{"month":5,"riseRate":0.555556,"avgChangeRate":0.187589},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.091514},{"month":7,"riseRate":0.7,"avgChangeRate":0.124373},{"month":8,"riseRate":0.6,"avgChangeRate":0.081761},{"month":9,"riseRate":0.3,"avgChangeRate":-0.115283},{"month":10,"riseRate":0.2,"avgChangeRate":-0.082714},{"month":11,"riseRate":0.5,"avgChangeRate":0.04477},{"month":12,"riseRate":0.3,"avgChangeRate":-0.058257}],"exchange":"NASDAQ","name":"Palvella Therapeutics","nameEN":"Palvella Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":{"directors":[{"name":"James Geraghty","position":"Director and Chairman"},{"name":"Stephen S. Yoder","position":"Director,Chief Executive Officer and President"},{"name":"Ann Barbier","position":"Director"},{"name":"Christopher Kiritsy","position":"Director"},{"name":"Jean Pierre Bizzari","position":"Director"},{"name":"Michael Richman","position":"Director"},{"name":"Steven Prelack","position":"Director"}],"executives":[{"name":"Stephen S. Yoder","position":"Director,Chief Executive Officer and President"},{"name":"Allan Reine","position":"Senior Vice President, Chief Financial Officer and Treasurer"},{"name":"Louis A. Matis","position":"Senior Vice President and Chief Development Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"PVLA","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":4},{"market":"US","date":"2024-11-13","symbol":"PVLA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.19},{"market":"US","date":"2024-08-14","symbol":"PVLA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-2.76},{"market":"US","date":"2024-05-15","symbol":"PVLA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-3.95},{"market":"US","date":"2024-04-23","symbol":"PVLA","defaultRemindTime":1713879000000,"type":"split","dateTimestamp":1713844800000,"forFactor":80,"toFactor":1,"ratio":80}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2025-04-01","current":44.513093,"percent":0.935484,"low":19.083855,"twenty":20.931809,"median":29.89804,"eighty":43.520732,"high":46.119317,"avg":30.09317,"sd":9.446978,"marketCap":314084382},"quantilePoints":[{"date":"2025-01-03","current":19.083855,"twenty":19.083855,"median":19.083855,"eighty":19.083855,"marketCap":134655684},{"date":"2025-01-10","current":22.662078,"twenty":19.083855,"median":20.077806,"eighty":23.120091,"marketCap":159903624},{"date":"2025-01-17","current":21.024047,"twenty":19.083855,"median":21.024047,"eighty":22.483962,"marketCap":148345678},{"date":"2025-01-24","current":20.658273,"twenty":19.395558,"median":20.960435,"eighty":22.003685,"marketCap":145764777},{"date":"2025-01-31","current":21.469337,"twenty":19.914003,"median":20.93658,"eighty":21.408905,"marketCap":151487644},{"date":"2025-02-07","current":23.854819,"twenty":20.19708,"median":20.960435,"eighty":22.191343,"marketCap":168319605},{"date":"2025-02-14","current":31.806426,"twenty":20.537409,"median":21.047902,"eighty":23.471552,"marketCap":224426140},{"date":"2025-02-21","current":30.216104,"twenty":20.626467,"median":21.159225,"eighty":24.999851,"marketCap":213204833},{"date":"2025-02-28","current":29.977556,"twenty":20.64237,"median":22.089563,"eighty":29.977556,"marketCap":211521636},{"date":"2025-03-07","current":38.072292,"twenty":20.658273,"median":23.043756,"eighty":30.804523,"marketCap":268638089},{"date":"2025-03-14","current":43.224933,"twenty":20.674177,"median":23.473142,"eighty":31.806426,"marketCap":304995124},{"date":"2025-03-21","current":43.622513,"twenty":20.674177,"median":24.864674,"eighty":35.527777,"marketCap":307800451},{"date":"2025-03-28","current":44.147319,"twenty":20.912725,"median":26.844623,"eighty":43.224933,"marketCap":311503482},{"date":"2025-04-01","current":44.513093,"twenty":20.931809,"median":29.89804,"eighty":43.520732,"marketCap":314084382}],"updateTime":1743655064655}}}